Literature DB >> 33704752

Lambda Red-Mediated Recombination in Shiga Toxin-Producing Escherichia coli.

Kenneth G Campellone1, Alyssa M Coulter2.   

Abstract

The bacteriophage Lambda (λ) "Red" recombination system has enabled the development of efficient methods for engineering bacterial chromosomes. This system has been particularly important to the field of bacterial pathogenesis, where it has advanced the study of virulence factors from Shiga toxin-producing and enteropathogenic Escherichia coli (STEC and EPEC). Transient plasmid-driven expression of Lambda Red allows homologous recombination between PCR-derived linear DNA substrates and target loci in the STEC/EPEC chromosomes. Red-associated techniques can be used to create individual gene knockouts, generate deletions of large pathogenicity islands, and make markerless allelic exchanges. This chapter describes specific strategies and procedures for performing Lambda Red-mediated genome engineering in STEC.

Entities:  

Keywords:  Allelic exchange; Bacterial genetics; EPEC; Enteropathogenic E. coli; Escherichia coli; Homologous recombination; Lambda Red; Recombineering; STEC; Shiga toxin-producing E. coli

Mesh:

Substances:

Year:  2021        PMID: 33704752     DOI: 10.1007/978-1-0716-1339-9_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use.

Authors:  S Björkman; H Sievertsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-06       Impact factor: 3.000

2.  Red-mediated recombineering of Salmonella enterica genomes.

Authors:  Frederik Czarniak; Michael Hensel
Journal:  Methods Mol Biol       Date:  2015

3.  A tyrosine-phosphorylated 12-amino-acid sequence of enteropathogenic Escherichia coli Tir binds the host adaptor protein Nck and is required for Nck localization to actin pedestals.

Authors:  Kenneth G Campellone; Andrew Giese; Donald J Tipper; John M Leong
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

4.  PCR-mediated gene replacement in Escherichia coli.

Authors:  K C Murphy; K G Campellone; A R Poteete
Journal:  Gene       Date:  2000-04-04       Impact factor: 3.688

5.  EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nck-independent actin assembly.

Authors:  Kenneth G Campellone; Douglas Robbins; John M Leong
Journal:  Dev Cell       Date:  2004-08       Impact factor: 12.270

6.  Dissecting virulence: systematic and functional analyses of a pathogenicity island.

Authors:  Wanyin Deng; José L Puente; Samantha Gruenheid; Yuling Li; Bruce A Vallance; Alejandra Vázquez; Jeannette Barba; J Antonio Ibarra; Paul O'Donnell; Pavel Metalnikov; Keith Ashman; Sansan Lee; David Goode; Tony Pawson; B Brett Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

7.  Attaching and effacing (A/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors.

Authors:  Massiel Cepeda-Molero; Cedric N Berger; Alistair D S Walsham; Samuel J Ellis; Simon Wemyss-Holden; Stephanie Schüller; Gad Frankel; Luis Ángel Fernández
Journal:  PLoS Pathog       Date:  2017-10-30       Impact factor: 6.823

8.  Gene doctoring: a method for recombineering in laboratory and pathogenic Escherichia coli strains.

Authors:  David J Lee; Lewis E H Bingle; Karin Heurlier; Mark J Pallen; Charles W Penn; Stephen J W Busby; Jon L Hobman
Journal:  BMC Microbiol       Date:  2009-12-09       Impact factor: 3.605

9.  Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli.

Authors:  Kenan C Murphy; Kenneth G Campellone
Journal:  BMC Mol Biol       Date:  2003-12-13       Impact factor: 2.946

10.  Lambda Red-mediated Recombineering in the Attaching and Effacing Pathogen Escherichia albertii.

Authors:  Marisa Egan; Jasmine Ramirez; Christian Xander; Chirag Upreti; Shantanu Bhatt
Journal:  Biol Proced Online       Date:  2016-02-03       Impact factor: 3.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.